MA (EU) number 
(Invented) name  Strength  Pharmaceutical 
form  
Route of 
administration 
Immediate 
Packaging 
Content 
(concentration)  
Pack size 
EU/1/04/0299/001 
  Fendrix 
EU/1/04/0299/002 
  Fendrix 
EU/1/04/0299/003 
  Fendrix 
  -1- 
  -1- 
  -1- 
Suspension for  
injection 
 Intramuscular use     pre-filled syringe 
    0.5 ml 
(glass)                                   
1 pre-filled syringe 
+ 1 needle 
Suspension for 
injection 
Suspension for 
injection 
 Intramuscular use     pre-filled syringe  
    0.5 ml 
1 pre-filled syringe  
(glass) 
 Intramuscular use     pre-filled syringe       
    0.5 ml 
10 pre-filled syringes 
(glass) 
1 
1 dose (0.5 ml) contains:  
Hepatitis B surface antigen 1, 2, 3 
1adjuvanted by AS04C containing: 
- 3-O-desacyl-4â€™- monophosphoryl lipid A (MPL) 2  
2adsorbed on aluminium phosphate (0.5 milligrams Al3+ in total) 
20 micrograms 
50 micrograms 
3produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology 
1/1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
